map Central

Directions Regarding Manufacture and Marketing of Unapproved Drug Products Containing Enclomiphene and Its Combinations

Updated on: 10th Aug, 2026
The Central Drugs Standard Control Organisation vide F. No. ENFORC-12016(11)/2/2026-eoffice-34479, issued Directions Regarding Manufacture and Marketing of Unapproved Drug Products Containing Enclomiphene and Its Combinations. Please refer the directions for more details.
Download download
PREVIOUS
Circular regarding Clarification on the Submission and Processing of Applications for Permission to Import and Market New Drugs Not Approved Anywhere in the World under the New Drugs and Clinical Trials Rules, 2019
NEXT
Draft notification of the Food Safety and Standards (Safe food and balanced diets for children in school) Amendment Regulations, 2026